Monte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID
|
|
|
- Thomasina Reynolds
- 5 years ago
- Views:
Transcription
1 Monte H. Moore, MD Idaho Physical Medicine and Rehabilitation Meridian, ID
2 Chronic pain brief review Opiates important things to know Factors in determining whether to use an opiate What to watch for if you decide to prescribe What to do if your patient fails to comply
3 Pain is the most common reason for physician consultation in the United States. It is a major symptom in many medical conditions, and can significantly interfere with a person's quality of life and general functioning.
4 sometimes pain persists despite removal of the stimulus and apparent healing of the body; and sometimes pain arises in the absence of any detectable stimulus, damage or disease.
5 3 months 6 months Pain that extends beyond the expected period of healing
6 Fear of injury Isolation Loss of work, $ and love, selfesteem Anxiety Depletion
7 Somatic or nociceptive: arthritis fracture post surgical acute musculoskeletal injuries
8 Central neuropathic: stroke fibromyalgia chronic pain with a strong psychological component
9 Peripheral neuropathic: compression neuropathy radiculopathy polyneuropathy postherpetic neuralgia phantom limb pain post amputation
10
11
12 May be more effective than other alternatives Low toxicity to gut, kidneys Intolerances to other drugs
13 Abuse potential Health risk, including death Risk of diversion Controversy regarding long term efficacy Irritating issues with patients who misuse opiates
14 5% of Americans over age 12 use prescription pain relievers for nonmedical purposes 70% obtain the medication from a friend or relative
15 Jefferson School of Population Health ,586 patients: 75% unlikely to be taking medications as prescribed 38% no detectable level of the drug prescribed 29% had a non-prescribed drug 27% had a level higher than expected 15% had a level lower than expected
16 Clinicians who prescribe opioids to treat chronic pain are often caught between their professional obligation to relieve suffering and their desire to avoid contributing to the non-medical consumption of controlled substances
17 Dependence Abstinence syndrome Tolerance Down regulation of opiate receptors Abuse Craving or Compulsion. Continued use despite adverse consequences Loss of Control
18 Behaviors that mimic addiction. May present in a patient with or without a history of or risk factors for drug abuse or true addiction. Often occurs in the setting of acute pain that is overlaid on a chronic pain condition. Climate of distrust and conflict between the patient and the care team related to the use of opioids for pain.
19 Pseudoaddiction
20 Neuropathic pain Significant comorbid psychopathology Long prior use of opiates (tolerance to opiates) Smoker Family history of chemical abuse
21 Function and quality of life will improve with a trial of increased opiates. Careful observation and knowledge of patient required
22 Nociceptive pain such as arthritis Psychologically stable Older patient No prior history of chemical abuse Non-smoker Negative family history of chemical abuse
23 Cognitive Hypotestosteronism in males and females Central sleep apnea Opioid-induced hyperalgesia
24 Sedation/impaired cognitive function Frequently in combination with other sedatives Patient usually unaware Family may be aware but may not see the connection or may not say anything Improves with reduction in dosage
25 Hypotestosteronism in males and females May be due to pituitary depletion from chronic pain Opioid suppression of GnRH in the hypothalamus Direct suppresion of testosterone production in the adrenal or gonads
26 Symptoms of low testosterone Lack of energy Loss of libido Depression Poor healing Diminished Opioid effects Apathy, weakness Suspect in any patient taking long term opiates Dose-related
27 Hypotestosteronism in males and females Reduces opioid receptor binding Treatable
28 Central sleep apnea Suppression of central breathing mechanism Fatigue, insomnia Reduced cognitive function Health risks of sleep apnea
29 Opioid-induced hyperalgesia Opioid neurotoxicity Enhanced sensitivity to painful stimuli Opioids may worsen initial pain & sensitivity to other sources of pain Often improves with opiate reduction
30 1. Evaluation of patient s expectations Document baseline function: Driving Cooking/cleaning Working Sleeping What does the patient want to be able to do? Are Goals realistic?
31 2. Is the pain likely to respond to low dose opiates? Somatic Neuropathic 3. Has there been a reasonable trial with non-opiate medications?
32 Nociceptive pain NSAIDs Tylenol Tramadol
33 Neuropathic pain Anticonvulsants Gabapentin (Neurontin) Pregabalin (Lyrica) Tiagabine (Gabitril) SNRI Venlafaxine (Effexor) Duloxetine (Cymbalta Milnacipran (Savella) Desvenlafaxine (Pristiq)
34 Neuropathic pain Muscle relaxers Lioresal (Baclofen) Deafferentation pain such as neuropathy or phantom limb pain Tizanidine (Zanaflex) Good for insomnia relating to neuropathic pain Tramadol Acts centrally at the opiate receptor and has potential for abuse, although less than other opiates May be effective for neuropathic pain
35 Neuropathic pain Tapendadol (Nucynta) Centrally acting analgesic u receptor agonist Norepinephrine uptake inhibitor Similar to hydrocodone in it s ability to relieve pain Electrical Stimulation
36 4. What other factors affect the pain and is there a way to address them? Deconditioning Behavioral reinforcers Depression and anxiety Smoking Testosterone Sleep disorders
37 physical therapy exercise injections surgery
38 5. Can you trust your patient? Your experience with patient Board of Pharmacy - Drug screens Other illegal activity : epository/start.do
39 ***OPIATE RISK TOOL*** FAMILY HISTORY: - alcohol abuse M3/F1 - illegal drug use M3/F1 - prescription drug abuse M4/F4
40 PERSONAL HISTORY: - alcohol abuse M3/F3 - illegal drug use M4/F4 - presciption drug abuse M5/F5
41 MENTAL HEALTH: - Dx of ADD, OCD, bipolar, schizophrenia M2/F2 - Dx of depression M1/F1
42 OTHER - age M1F1 - history of preadolescent sexual abuse M0/F3 TOTAL: SCORING: 0-3 low risk 4-7 moderate risk 8 or greater high risk
43 6. What are the medical risks to your patient if opiates are used? Drug interactions (other sedating medications) CNS dysfunction Sleep disturbance Liver disease Hypotestosteronism Risk of abuse and diversion
44 Set up clear expectations chronic pain agreement Continue to utilize non-opiates, lifestyle change, and other reasonable interventions to every extent possible Watch for drug interactions Evaluate whether the opiate is achieving the initial goals Monitor for compliance Monitor for side effects and interactions
45 Treat concurrent mental health disorders Be sensitive to medication costs Check for low testosterone and sleep apnea, especially if taking high doses Educate, educate, educate why you don t want to ask me to increase your dose today
46 Face to face conversation explaining why you aren t comfortable prescribing Refer rather than abandoning - consider referral for addiction evaluation Consider pain specialist
47 The challenge is to curtail the abuse and diversion of prescription opioids while ensuring their availability for patients who benefit from their use. Lynn R. Webster
48 The obligations to battle pain and addiction are not mutually exclusive, they are mutually inextricable Lynn R. Webster
Opioids in the Management of Chronic Pain: An Overview
Opioids in the Management of Chronic Pain: An Overview Appropriate treatment of chronic pain may include both pharmacologic and non-pharmacologic modalities. The Board realizes that controlled substances,
SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)
9 SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF ACUTE PAIN NONOPIOID TREATMENTS
Managing the Chronic Pain Patient. (and some stuff about opioids)
Managing the Chronic Pain Patient. (and some stuff about opioids) C. Patrick Carroll, M.D. Assistant Professor Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences
Treating Pain and Depression
Treating Pain and Depression Without Getting Depressed Joseph P, Arpaia, MD www.jparpaiamd.com More than 50% of patients with chronic pain also have clinically significant depression. Interestingly that
Neuropathic Pain and Pain Management Options. Mihnea Dumitrescu, MD
Neuropathic Pain and Pain Management Options Mihnea Dumitrescu, MD www.austinppc.com International Association for the Study of Pain (IASP): Definition of Pain Pain is an unpleasant sensory and emotional
Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation
Learning Objectives Effective, Safe Analgesia An Approach to Appropriate Outpatient Chronic Pain Treatment By the end of this presentation, participants will be able to: Identify multiple factors that
If Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017
If Not Opioids then what LEAH EDMONDS CSHP OCTOBER 26, 2017 Disclosure Nothing to disclose Objectives Identify various non-opioid options for the treatment of chronic non cancer pain Choose appropriate
solutions MEDICATION MIS MANAGEMENT and Chronic Pain 10/4/2016 Opioid Abuse: Current Data Opioid Abuse: Current Data
MEDICATION MIS MANAGEMENT and Chronic Pain solutions Opioid Abuse: Current Data Americans consume 80% of the global supply of opioids This includes 99% of the world s hydrocodone and 2/3s of the world
Subject: Pain Management (Page 1 of 7)
Subject: Pain Management (Page 1 of 7) Objectives: Managing pain and restoring function are basic goals in helping a patient with chronic non-cancer pain. Federal and state guidelines require that all
An unpleasant sensory and emotional experience associated with actual or potential tissue damage.
An unpleasant sensory and emotional experience associated with actual or potential tissue damage. Acute Pain results from disease, inflammation or injury to tissues; generally comes on suddenly and may
Knock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS
POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS November 9, 2018 Aimee LaMere, CNP Molly McNaughton, CNP Leslie Weide, MSW, LICSW, ACM Disclosures: Conflict of interest statement: We certify that,
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Lucas Buffaloe, MD Associate Professor of Clinical Family and Community Medicine University of Missouri Health Care Goals for today
Medications for the Treatment of Neuropathic Pain
Medications for the Treatment of Neuropathic Pain February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation Neuropathic Pain Pain, paresthesias, and sensory
OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS
OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS This leaflet aims to help you understand your pain, so that you can work with your health care team to self-manage your symptoms and improve your quality
Chronic Pain: Advances in Psychotherapy
Questions from chapter 1 Chronic Pain: Advances in Psychotherapy 1) Pain is a subjective experience. 2) Pain resulting from a stimulus that would normally not produce pain such as a breeze is a) analgesia
A Patient s Guide to The Medication Approach to Chronic Pain
A Patient s Guide to The Medication Approach to Chronic Pain 651 Old Country Road Plainview, NY 11803 Phone: 5166818822 Fax: 5166813332 p.lettieri@aol.com DISCLAIMER: The information in this booklet is
9/30/2017. Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management. Program Objectives. Impact of Poorly Managed Pain
Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management MARY BETH PARTYKA MSN ADULT NURSE PRACTITIONER ADVOCATE CHRIST MEDICAL CENTER ADULT PAIN SERVICE Program Objectives Identify
Colorado State Board of Medical Examiners Policy
POLICY NUMBER: 10-14 Title: Guidelines for the Use of Controlled Substances for the Treatment of Pain Date Issued: May 16, 1996 Date(s) Revised: November 18, 2004 Reference: 12-36-117, C.R.S. Purpose:
UnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 3019-9 Program Step Therapy Medication Lyrica capsules, Lyrica Solution, Lyrica CR tablets* (pregabalin) P&T Approval Date 1/08,
Understanding pain and mental illness Impact on management principles
Understanding pain and mental illness Impact on management principles Chris Alderman Consultant Psychopharmacologist Pain and mental illness - context PAIN MENTAL ILLNESS OTHER FACTORS (personality, history.
Recognizing Narcotic Abuse and Addiction and Helping Those With It
Recognizing Narcotic Abuse and Addiction and Helping Those With It Michael McNett, MD Medical Director for Chronic Pain Member, WI Med Society Opioid Subcommittee Ancient History 1995: OxyContin approved
Practical Pain Management Leah Centanni, MSN, FNP-C, Asst. Clinical Professor CANP Conference March 22, 2014
Practical Pain Management Leah Centanni, MSN, FNP-C, Asst. Clinical Professor CANP Conference March 22, 2014 Overview Types of Pain Physical Examination of Pain Pharmacologic Approach in Pain Management
Pain CONCERN. Medicines for long-term pain. Antidepressants
Pain CONCERN Medicines for long-term pain Antidepressants Many people living with long-term pain (also known as chronic or persistent pain) are worried about using medicines like antidepressants. They
CHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
PAIN TERMINOLOGY TABLE
PAIN TERMINOLOGY TABLE TERM DEFINITION HOW TO USE CLINICALLY Acute Pain Pain that is usually temporary and results from something specific, such as a surgery, an injury, or an infection Addiction A chronic
Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with
Headaches, 37, 42 Hypnotherapy, 101t, 106 Hypothalamic-pituitary-adrenal (HPA) axis, 59, 61, 63, 64, 65
INDEX Note: page numbers in italic typeface indicate figures. Page numbers followed by a t indicate tables. Abbreviations are for terms listed on pages 135-137. Acetaminophen/tramadol in fibromyalgia,
Proposed Revision to Med (i)
Proposed Revision to Med 501.02 (i) I. Purpose This rule has been adopted to enable the Board to best protect public health and safety while providing a framework for licensees to effectively treat and
IMPROVING CHRONIC PAIN PATIENTS QUALITY OF LIFE WITH CUTTING EDGE TECHNOLOGY. Jacqueline Weisbein, DO Napa Valley Orthopaedic Medical Group
IMPROVING CHRONIC PAIN PATIENTS QUALITY OF LIFE WITH CUTTING EDGE TECHNOLOGY Jacqueline Weisbein, DO Napa Valley Orthopaedic Medical Group Who Am I? Avid equestrian Trained in Physical Medicine & Rehabilitation
HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
No Pain, No Gain Pharmacy Patient Pain Counseling Competition
No Pain, No Gain Pharmacy Patient Pain Counseling Competition Offered by the Maine Pharmacy Association as part of the 2010 MPA Fall Conference Sponsored by an educational grant by NASPA and Purdue Pharma,
No disclosures for any of the speakers!
Opiate Use Disorders and Pain in the elderly: Integrating care with the pain specialist Gabriel Paulian M.D Christopher Ong, M.D Yuliet Sanchez, M.D Uma Suryadevara, M.D No disclosures for any of the speakers!
MANAGEMENT OF VISCERAL PAIN
MANAGEMENT OF VISCERAL PAIN William D. Chey, MD, FACG Professor of Medicine University of Michigan 52 year old female with abdominal pain 5 year history of persistent right sided burning/sharp abdominal
Rational Polypharmacy
Rational Polypharmacy Thomas B. Gregory, PharmD, BCPS, CPE, FASPE Disclosures Clinical advisory board: Daiichi Sankyo 1 Introduction Cox Health Ambulatory Pain Clinic Pharmacy Specialist Learning Objectives
Neuropathic Pain in Palliative Care
Neuropathic Pain in Palliative Care Neuropathic Pain in Advanced Cancer Affects 40% of patients Multiple concurrent pains are common Often complex pathophysiology with mixed components Nocioceptive Neuropathic
3/3/2015 CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN
CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN 1 Pain that persists or recurs > 3-6 months Pain that persists >1 month after injury/event Commonly seems out of proportion to the physical process Cause may be
Describe Identify Compare Recognize
Goal To educate nurses about the challenges associated with treating chronic pain and the safety and efficacy of alternative therapy options in relation to Opioids. Objectives Describe the challenges associated
Hospital Based Opioid Management A case based, peer discussion
Hospital Based Opioid Management A case based, peer discussion A NNA MURLEY SQUIBB M.D. A S S O C I A T E P R O G R A M D I R E C T O R, S O I N F A M I L Y M E D I C I N E R E S I D E N C Y Disclosures
Tips for Pain Management
Tips for Pain Management Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health Management By: James J. Messina, Ph.D. What are the medical
Neuropathic pain (pain due to nerve damage)
Neuropathic pain (pain due to nerve damage) Clinical Guideline Pain can be nociceptive, neuropathic or mixed. The neuropathic component of pain generally responds poorly to conventional analgesics. Consider
Non-Opioid Drugs to Treat Neuropathic Pain. March 2018
Non-Opioid Drugs to Treat Neuropathic Pain Final Report March 2018 This report is intended only for state employees in states participating in the Drug Effectiveness Review Project (DERP). Do not distribute
D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine
D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships
Neuropathic Pain Treatment Guidelines
Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,
Where is your pain located? Please use the diagram below to indicate where most of your pain is located.
Name: Address: Social Security Number: Email Address: Emergency Contact: Primary Care Physician: Name: Address: Phone Number: Date of Birth: Today's date: Cell Phone Number: Phone #: Referring Physician:
Chronic Pain Pharmacist role in the clinic
Chronic Pain Pharmacist role in the clinic WSPA Annual Meeting 2015 Alvin Goo, PharmD Clinical Associate Professor University of Washington Schools of Pharmacy and Family Medicine Speakers Declaration
Opioid Analgesic Treatment Worksheet
Opioid Analgesic Treatment Worksheet Aetna Better Health of Louisiana Fax: 1 844 699 2889 www.aetnabetterhealth.com/louisiana/providers/pharmacy LA Legacy Fee for Service (FFS) Medicaid Fax: 1 866 797
I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4
SUTTER MEDICAL FOUNDATION (SMF) 2750 GATEWAY OAKS DRIVE, #150 SACRAMENTO, CA 95833 SPA PCP Treatment & Referral Guidelines PAIN MANAGEMENT Developed June 1, 2003 Revised (Format Revisions) November 13,
IEHP UM Subcommittee Approved Authorization Guidelines Referrals to Pain Management Specialists
IEHP Policy: Based on a review of the currently available literature and community standards of practice, the IEHP UM Subcommittee will consider referrals to Pain Management Specialists medically necessary
HealthPartners Inspire Special Needs Basic Care Clinical Care Planning and Resource Guide CHRONIC PAIN
The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH National Institute of Neurological Disorders and Stroke), Mount Sinai Beth Israel
Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain
Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This
1) On a scale of 1 10, how would you rate your pain Most of the time, 0 being pain free and 10 being most severe?
Patient Survey Results 1) On a scale of 1 10, how would you rate your pain Most of the time, 0 being pain free and 10 being most severe? Mild (Annoying but little interference with daily Life Moderate
Syllabus. Questions may appear on any of the topics below: I. Multidimensional Nature of Pain
Questions may appear on any of the topics below: I. Multidimensional Nature of Pain Syllabus A. Epidemiology 1. Pain as a public health problem with social, ethical, legal and economic consequences 2.
Antidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
Adult Health History Form Preferred Name: 1
Adult Health History Form Preferred Name: 1 Your answers on this form will help your health care provider get an accurate history of your medical concerns and conditions. If you are uncomfortable with
IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?
NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this
Choose a category. You will be given the answer. You must give the correct question. Click to begin.
Instructions for using this template. Remember this is Jeopardy, so where I have written Answer this is the prompt the students will see, and where I have Question should be the student s response. To
PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT
PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT Brandy Ficek, MD Medical Director of Quality of Life and Palliative Medicine Cancer Treatment Centers of America Rocky Mountain Blood Cancer
Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals
Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management The Johns Hopkins Hospital Objectives and Disclosures
KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998
KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble
Making sense of fibromyalgia syndrome. Charles Radis D.O. Clinical Professor of Medicine UNECOM
Making sense of fibromyalgia syndrome Charles Radis D.O. Clinical Professor of Medicine UNECOM Goals 1. How do we diagnose fibromyalgia syndrome in patients presenting with widespread pain? 2. Discuss
What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
Conflicts of Interests: None
A Review of Evidence-Pain Management and Therapeutic Options to Prevent Opioid Addiction Graves T. Owen, MD Chairman of the Board Texas Pain Foundation Conflicts of Interests: None 1 Chronic Pain Assessment
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD and Kellie Bunn, PA-C What are functional GI
Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am
Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am Tim R Brown, PharmD, BCACP, FASHP Director of Clinical Pharmacotherapy Cleveland Clinic Akron General Center for Family
Based on Tip 54. Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders KAP KEYS FOR CLINICIANS
Based on Tip 54 Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders KAP KEYS FOR CLINICIANS KAP Keys Based on TIP 54 Introduction KAP Keys were developed to accompany the Treatment
Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory
Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine
Legacy Pain Management Center New Patient Questionnaire
Legacy Pain Management Center New Patient Questionnaire Please complete this form prior to your visit to allow us to make the best use of our time together. Primary Care Provider: Referring Physician:
Overview of Neuropathic pain
Overview of Neuropathic pain Kongkiat Kulkantrakorn,M.D. Neurology division Thammasat University 1 Contents Overview of pain New concepts and mechanism Treatment options New data in management 2 3 Breaking
Disclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws
Disclosures Management of Chronic, Non- Terminal Pain No financial disclosures or conflicts of interest to report Michael A. Smith, PharmD, BCPS Clinical Assistant Professor, University of Michigan College
FIBROMYALGIA. Raj Saini Greenbrook Pharmacy
FIBROMYALGIA Raj Saini Greenbrook Pharmacy www.greenrx.ca 519-742-9955 OBJECTIVES Introduction Causes/Symptoms/Diagnosis Stress, Hormonal Balance & Fibromyalgia Treatment-Pharmaceutical Treatment-Natural
CHRONIC PELVIC PAIN AS WE UNDERSTAND IT TODAY. Dr. Sonia Wartan Consultant in Pain Medicine
CHRONIC PELVIC PAIN AS WE UNDERSTAND IT TODAY Dr. Sonia Wartan Consultant in Pain Medicine Clinical Lead of Chronic Pain Services Chronic Pelvic MDT Clinic Royal Gwent Hospital Acute Pain Specific disease/injury
Analgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
Risk Reduction Strategies in Pain Management
Risk Reduction Strategies in Pain Management Melissa J. Durham, PharmD, MACM, BCACP, DAAPM Assistant Professor of Clinical Pharmacy USC School of Pharmacy Clinical Pharmacist, The USC Pain Center Learning
Opiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
Acute pain management in opioid tolerant patients. Muhammad Laklouk
Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)
Pain Signaling Neuropathic Pain Distinctly different from nociceptive pain Sustained by abnormal processing of sensory input by the peripheral or cent
Objectives Pharmacologic Management of Neuropathic Pain Joseph R. Ineck, Pharm.D.,., CPE Pharmacist: St. Luke s Health System At the conclusion of this presentation, pharmacists will be able to: 1. Differentiate
Pain Assessment & Management. For General Nursing Orientation
Pain Assessment & Management For General Nursing Orientation April 2012 Overview Definition of pain Barriers to effective pain management Types of pain Objective pain assessment Approaches to management
Fibromyalgia: are you a believer?
Fibromyalgia: are you a believer? Shorin Nemeth, DO, FACOI Medical Director Comprehensive Pain Services Medical Director Oncology Palliative Care Providence Health and Services Portland, OR Disclosures
NBPDP Drug Utilization Review Process Update
Bulletin # 802 December 1, 2010 NBPDP Drug Utilization Review Process Update The New Brunswick Prescription Drug Program (NBPDP) employs a Drug Utilization Review (DUR) process which identifies, investigates
Pain 101: An Introduction to Chronic Pain & Pain Management
Pain 101: An Introduction to Chronic Pain & Pain Management CRC HEALTH GROUP What is Pain? The International Association for the Study of Pain defines pain as follows: Pain is an unpleasant sensory and
Opioid Analgesic Treatment Worksheet
Opioid Analgesic Treatment Worksheet Aetna Better Health of Louisiana Fax: 1 844 699 2889 www.aetnabetterhealth.com/louisiana/providers/pharmacy LA Legacy Fee for Service (FFS) Medicaid Fax: 1 866 797
Clinical and Contextual Evidence Reviews
Clinical and Contextual Evidence Reviews Roger Chou, MD Professor of Medicine Oregon Health & Science University Director, Pacific Northwest Evidence-based Practice Center Purpose Summarize methods for
IEHP UM Subcommittee Approved Authorization Guidelines Referrals to Pain Management Specialists
IEHP Policy: Based on a review of the currently available literature and community standards of practice, the IEHP UM Subcommittee will consider referrals to Pain Management Specialists medically necessary
Disclosures & Warnings
A truly multidisciplinary approach to managing pain and fatigue Howard P. Levy, M.D., Ph.D. Assistant Professor, Johns Hopkins University August 2, 2013 Ehlers Danlos National Foundation 2013 National
Opioids in Pain and Addiction
Opioids in Pain and Addiction Walter Ling MD Integrated Substance Abuse Programs Dept. of Psychiatry, UCLA CSAM Seminar San Francisco CA October 9, 2009 lwalter@ucla.edu www.uclaisap.org Pain and Addiction:
Summary of Pain Management Issues
Chapter 2 / Frequent Treatment Concerns 11 Summary of Pain Management Issues Frequent Concerns in Treating Chronic Pain Patients 2 Chronic pain patients often come to their doctors with a myriad of complaints
H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.
H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been
MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014
MAT for Opioid Dependence Methadone maintenance treatment (MMT) Buprenorphine/naloxone (suboxone) Buprenorhine/naloxone (BupNX) Buprenorphine SL Parenteral naltrexone (P-ntx) Oral naltrexone (ntx) MAT
3/7/2018. IASP updated definition of pain. Nociceptive Pain. Transduction. (Nociceptors) Transmission. (Peripheral nerve) Modulation
IASP updated definition of pain The Pain of Trauma and The Trauma of Pain: The Opioid Crisis is Not What You Think. Bennet Davis, M.D. Many people report pain in the absence of tissue damage or any likely
Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine
Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine International Association for the Study of Pain "Pain is an unpleasant sensory and emotional experience associated with actual or potential
Pain Management: Overview of A Practical Approach
Pain Management: Overview of A Practical Approach Michael B. Potter, M.D. Department of Family and Community Medicine University of California, San Francisco What is Pain? An unpleasant sensory and emotional
Substance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
PERIPHERAL NEUROPATHY. Maureen Gallagher Jesse James Maldonado
PERIPHERAL NEUROPATHY Maureen Gallagher Jesse James Maldonado Objectives What is peripheral neuropathy? Symptoms Causes Treatment goals What are the available treatment options? Prescription drug therapy
In clinical studies, gabapentin efficacy was demonstrated over a range of doses from 1800 mg/day to 3600 mg/day (1-3).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.17 Subject: Gabapentin Page: 1 of 6 Last Review Date: June 22, 2017 Gabapentin Description Gabapentin
Gateshead Pain Guidelines for Chronic Conditions
Gateshead Pain Guidelines for Chronic Conditions Effective Date: 13.2.2013 Review Date: 13.2.2015 Gateshead Pain Guidelines: Contents PAIN GUIDELINES Chronic Non-Malignant Pain 5 Musculoskeletal Pain 6
PAIN INFORMATION SHEET
PAIN INFORMATION SHEET PLEASE MARK THE AREAS ON YOUR BODY WHERE YOU FEEL THE SENSATIONS DESCRIBED BELOW. PLEASE USE THE APPROPRIATE SYMBOL & INCLUDE ALL AREAS. **** ==== OOOO XXXX //// ACHE **** NUMBNESS
Avera ecare Chronic Pain Management Janell Simpkins MD, FACP Avera ecare Specialty Clinic Medical Director
Chronic Pain Management Janell Simpkins MD, FACP Avera ecare Specialty Clinic Medical Director Burden of Pain 100 million Americans report ongoing pain 25 million with daily pain Pain impacts health status,
Available Strengths Limits. 10 mg tablet -- $ mg tablet -- $ mg tablet -- $ mg tablet -- $72.41 Avoid use in members over
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Fibromyalgia P&T DATE: 5/9/2017 CLASS: Pain Management REVIEW HISTORY 9/15, 5/14, 11/12, 9/12, LOB: Medi-Cal (MONTH/YEAR)
Controlled Substance and Wellness Agreement
Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)